Full Prescribing Information   |   U.S. Consumers

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

IMPORTANT SAFETY INFORMATION
CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

You can continue to read Important Safety Information at the bottom of this page


 

Formulation & benefits

Help with many of the little surprises pregnancy delivers

A prenatal vitamin's most important job is to deliver the nutrients that support fetal growth and development. The health and well-being of your pregnant patients matter as well.

That's why PreferaOB ONE® offers nourishing ingredients for both babies and moms.

Nine months of exciting physical changes are in store for most women. However, these changes are often accompanied by less welcome physiological reactions.

PreferaOB ONE® is formulated to help expectant mothers with those discomforts. For instance:

Constipation:

A unique combination of heme and nonheme iron increases the overall absorption by up to 40% and acts to reduce the likelihood of experiencing constipation.1
LEARN MORE
 

Fatigue:

The same dual combination of iron that's better absorbed also helps patients maintain their energy levels.2-4
LEARN MORE
 

Nausea and vomiting:

Vitamin B6 can help treat morning sickness in high concentrations. PreferaOB ONE® vitamins contain 50 mg of vitamin B6, one of the highest doses of any prenatal.5,6
LEARN MORE

INDICATIONS AND USAGE: PreferaOB ONE® is a prescription multivitamin/multimineral nutritional supplement with Omega-3 fatty acid (life'sDHA™) indicated for use in improving the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and non-lactating mothers. PreferaOB ONE® is also beneficial in improving the nutritional status of women prior to conception.

IMPORTANT SAFETY INFORMATION

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

CONTRAINDICATIONS: This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING: Ingestion of more than 3 grams of Omega-3 fatty acids per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of Omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding diathesis.

PRECAUTIONS: Folic acid when administered as a single agent in doses above 0.1 mg daily may obscure pernicious anemia in that hematological remission can occur while neurological manifestations remain progressive. Pregnant women and nursing mothers should avoid supplemental doses of vitamin E higher than RDA amounts. While prescribing this nutritional supplement for pregnant women, nursing mothers, or for women prior to conception, their medical condition and other drugs, herbs, and/or supplements consumption should be considered.

ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Full Prescribing Information.

References

1. Frykman E, Bystrom M, Jansson U, Edberg A, Hansen T. Side effects of iron supplements in blood donors: superior tolerance of heme iron. J Lab Clin Med. 1994;123(4):561-564. 2. Lee KA, Zaffke ME. Longitudinal changes in fatigue and energy during pregnancy and the postpartum period. J Obstet Gynecol Neonatal Nurs. 1999;28(2):183-191. 3. Zimmerman MB, Hurrell RF. Nutritional iron deficiency. Lancet. 2007;370(9586):511-520. 4. Ekman M, Reizenstein P. Comparative absorption of ferrous and heme-iron with meals in normal and iron deficient subjects. Z Emahrungswiss. 1993;32(1):67-70. 5. Davis M. Nausea and vomiting of pregnancy: an evidence-based review. J Perinat Neonatal Nurs. 2004;18(4):312-328. 6. American College of Obstetrics and Gynecology. ACOG (American College of Obstetrics and Gynecology) Practice Bulletin: nausea and vomiting of pregnancy. Obstet Gynecol. 2004;103(4):803-814.